Patent details
EP1272195 Title: USE OF FULVESTRANT IN THE TREATMENT OF RESISTANT BREAST CANCER
Basic Information
- Publication number:
- EP1272195
- PCT Application Number:
- PCT/GB/2001/001500
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP019172899
- PCT Publication Number:
- WO/2001/074366
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF FULVESTRANT IN THE TREATMENT OF RESISTANT BREAST CANCER
- French Title of Invention:
- UTILISATION DE FULVESTRANT DANS LE TRAITEMENT DU CANCER RESISTANT DU SEIN
- German Title of Invention:
- VERWENDUNG VON FULVESTRANT IN DER BEHANDLUNG VON RESISTENTEM BRUSTKREBS
- SPC Number:
Dates
- Filing date:
- 02/04/2001
- Grant date:
- 12/10/2005
- EP Publication Date:
- 12/10/2005
- PCT Publication Date:
- 11/10/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/01/2003
- EP B1 Publication Date:
- 12/10/2005
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 02/04/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/04/2001
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Agent
- Name:
- VAN MALDEREN MICHEL
- From:
- 24/11/2005
- Address:
- ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- THURLIMANN Beat
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 0008172
- Priority Date:
- 05/04/2000
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 31/565;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 24/03/2020
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|